GAM
ABBV icon

Generali Asset Management’s AbbVie ABBV Stock Holding History

Generali Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.5M Sell
80,486
-5,924
-7% -$1.31M 0.37% 62
2025
Q4 		$19.7M Buy
86,410
+8,288
+11% +$1.89M 0.4% 50
2025
Q3 		$18.1M Sell
78,122
-6,172
-7% -$1.26M 0.39% 58
2025
Q2 		$15.6M Buy
84,294
+245
+0.3% +$45.5K 0.36% 60
2025
Q1 		$17.6M Sell
84,049
-24,502
-23% -$4.76M 0.43% 42
2024
Q4 		$19.3M Buy
+108,551
New +$20M 0.49% 38

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Generali Asset Management's ABBV Position: Q1 2026 in Review

Generali Asset Management reduced its AbbVie (ABBV) stake by 6.9% in Q1 2026, selling an estimated $1.31M and leaving 80,486 shares worth $17.5M. The position accounts for 0.37% of the portfolio, ranked #62.

Generali Asset Management first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $19.7M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Generali Asset Management held 80,486 shares of AbbVie worth $17.5M as of Q1 2026.
  • Generali Asset Management sold 5,924 AbbVie shares in Q1 2026, an estimated $1.31M.
  • AbbVie made up 0.37% of Generali Asset Management's portfolio in Q1 2026, its #62 holding.
  • Generali Asset Management first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Generali Asset Management's AbbVie position peaked at $19.7M in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Generali Asset Management's 13F filing for Q1 2026, filed 5 May 2026.